Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CANC NASDAQ:DEMZ NASDAQ:PABD NASDAQ:SARK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$30.05+0.9%$28.10$20.10▼$30.64$83.83M1.1114,113 shs3,451 shsDEMZDemocratic Large Cap Core ETF$43.42+1.0%$41.34$29.70▼$43.48$50.80M1.043,407 shs2,108 shsPABDiShares Paris-Aligned Climate MSCI World ex USA ETF$64.17+0.2%$62.73$49.12▼$64.54$248.33M0.7819,162 shs470 shsSARKTradr 1X Short Innovation Daily ETF$27.53-1.5%$30.37$26.68▼$82.71$103.79M-1.62522,026 shs575,630 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF+0.92%-0.28%+10.32%+11.53%+8.31%DEMZDemocratic Large Cap Core ETF+0.98%+3.06%+5.03%+9.04%+21.22%PABDiShares Paris-Aligned Climate MSCI World ex USA ETF+0.16%+0.34%+2.17%+5.09%+17.74%SARKTradr 1X Short Innovation Daily ETF-1.50%-3.57%-7.59%-15.60%-67.03%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCANCTema Oncology ETF$30.05+0.9%$28.10$20.10▼$30.64$83.83M1.1114,113 shs3,451 shsDEMZDemocratic Large Cap Core ETF$43.42+1.0%$41.34$29.70▼$43.48$50.80M1.043,407 shs2,108 shsPABDiShares Paris-Aligned Climate MSCI World ex USA ETF$64.17+0.2%$62.73$49.12▼$64.54$248.33M0.7819,162 shs470 shsSARKTradr 1X Short Innovation Daily ETF$27.53-1.5%$30.37$26.68▼$82.71$103.79M-1.62522,026 shs575,630 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCANCTema Oncology ETF+0.92%-0.28%+10.32%+11.53%+8.31%DEMZDemocratic Large Cap Core ETF+0.98%+3.06%+5.03%+9.04%+21.22%PABDiShares Paris-Aligned Climate MSCI World ex USA ETF+0.16%+0.34%+2.17%+5.09%+17.74%SARKTradr 1X Short Innovation Daily ETF-1.50%-3.57%-7.59%-15.60%-67.03%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCANCTema Oncology ETF 2.77Moderate Buy$30.05N/ADEMZDemocratic Large Cap Core ETF 2.72Moderate Buy$43.42N/APABDiShares Paris-Aligned Climate MSCI World ex USA ETF 0.00N/AN/AN/ASARKTradr 1X Short Innovation Daily ETF 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCANCTema Oncology ETFN/AN/AN/AN/AN/AN/ADEMZDemocratic Large Cap Core ETFN/AN/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/AN/AN/AN/AN/ASARKTradr 1X Short Innovation Daily ETFN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCANCTema Oncology ETFN/AN/A20.39∞N/AN/AN/AN/AN/ADEMZDemocratic Large Cap Core ETFN/AN/A28.63∞N/AN/AN/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/AN/A18.58∞N/AN/AN/AN/AN/ASARKTradr 1X Short Innovation Daily ETFN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCANCTema Oncology ETF$0.722.40%N/AN/AN/ADEMZDemocratic Large Cap Core ETF$0.190.44%N/AN/AN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETF$1.462.28%N/AN/AN/ASARKTradr 1X Short Innovation Daily ETF$6.5123.65%N/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCANCTema Oncology ETFN/ADEMZDemocratic Large Cap Core ETFN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/ASARKTradr 1X Short Innovation Daily ETFN/AInsider OwnershipCompanyInsider OwnershipCANCTema Oncology ETFN/ADEMZDemocratic Large Cap Core ETFN/APABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/ASARKTradr 1X Short Innovation Daily ETFN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCANCTema Oncology ETFN/A2.79 millionN/ANot OptionableDEMZDemocratic Large Cap Core ETFN/A1.17 millionN/ANot OptionablePABDiShares Paris-Aligned Climate MSCI World ex USA ETFN/A3.87 millionN/AN/ASARKTradr 1X Short Innovation Daily ETFN/A3.77 millionN/AOptionableSARK, CANC, PABD, and DEMZ HeadlinesRecent News About These CompaniesTradr 1X Short Innovation Daily ETF (NASDAQ:SARK) Trading Up 2.3% - Still a Buy?October 17, 2025 | americanbankingnews.comTradr 1X Short Innovation Daily ETF (SARK) Dividend HistoryJuly 12, 2025 | nasdaq.comTradr 2X Short TSLA Daily ETF Short Interest Report | NASDAQ:TSLQ | BenzingaApril 24, 2025 | benzinga.comTradr 2X Short Innovation Daily ETFApril 4, 2025 | morningstar.comMTop Performing Leveraged/Inverse ETFs: 03/16/2025March 19, 2025 | etftrends.comETop Performing Leveraged/Inverse ETFs: 03/02/2025March 5, 2025 | etftrends.comETop Performing Leveraged/Inverse ETFs: 02/23/2025February 25, 2025 | etftrends.comELearn to Evaluate (SARK) using the ChartsJanuary 17, 2025 | news.stocktradersdaily.comN(SARK) Investment ReportDecember 17, 2024 | news.stocktradersdaily.comN(SARK) Trading SignalsDecember 6, 2024 | news.stocktradersdaily.comN(SARK) Pivots Trading Plans and Risk ControlsNovember 15, 2024 | news.stocktradersdaily.comN(SARK) Technical DataNovember 5, 2024 | news.stocktradersdaily.comN(SARK) Proactive StrategiesOctober 14, 2024 | news.stocktradersdaily.comNInvestment Managers Series Trust II - Tradr 2X Long Triple Q Quarterly ETFOctober 3, 2024 | money.usnews.comInvestment Managers Series Trust II - Tradr 2X Long SPY Quarterly ETFOctober 3, 2024 | money.usnews.comWhen (SARK) Moves Investors should ListenSeptember 23, 2024 | news.stocktradersdaily.comNSPYB Tradr 2X Long SPY Weekly ETFSeptember 18, 2024 | seekingalpha.comTradr 2X Long SOXX Weekly ETF (SOXW)September 11, 2024 | investing.comTradr 2X Long SPY Weekly (SPYB)September 11, 2024 | investing.comInvestment Managers Series Trust II - Tradr 2X Long SPY Weekly ETFSeptember 5, 2024 | money.usnews.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSARK, CANC, PABD, and DEMZ Company DescriptionsTema Oncology ETF NASDAQ:CANC$30.05 +0.27 (+0.89%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$30.04 0.00 (0.00%) As of 10/24/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Tema Oncology ETF (CANC) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed, investing in stocks of companies focused on cancer treatment and management from issuers all around the world. The fund uses a bottom-up approach to select pioneering companies at perceived attractive valuations CANC was launched on Aug 15, 2023 and is issued by Tema.Democratic Large Cap Core ETF NASDAQ:DEMZ$43.42 +0.43 (+1.00%) Closing price 10/24/2025 03:52 PM EasternExtended Trading$43.44 +0.02 (+0.05%) As of 10/24/2025 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Democratic Large Cap Core ETF (DEMZ) is an exchange-traded fund that is based on the Democratic Large Cap Core index. The fund tracks an index of US large-cap companies whose employees are highly supportive of Democratic candidates. DEMZ was launched on Nov 2, 2020 and is managed by RAM.iShares Paris-Aligned Climate MSCI World ex USA ETF NASDAQ:PABD$64.17 +0.10 (+0.16%) As of 10/24/2025 03:57 PM EasternThe iShares Paris-Aligned Climate MSCI World ex USA ETF (PABD) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a tier-weighted index of large- and mid-cap stocks in developed markets excluding the US. The fund utilizes ESG criteria aligned with the Paris Climate Agreement when selecting and weighing securities. PABD was launched on Feb 8, 2022 and is issued by BlackRock.Tradr 1X Short Innovation Daily ETF NASDAQ:SARK$27.53 -0.42 (-1.50%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$27.44 -0.09 (-0.31%) As of 10/24/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The AXS Short Innovation Daily ETF (SARK) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively-managed fund that seeks to achieve -1x the return, for a single day, of the ARK Innovation ETF (ARKK) through swap agreements with major global financial institutions. SARK was launched on Nov 9, 2021 and is managed by AXS Investments. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 10/20 - 10/24 Freeport-McMoRan Posts Strong Earnings Despite Indonesia Shutdown Tesla’s Earnings Review: Does the Juice Justify the Squeeze? Warner Bros. Bidding War Potential: How High Could WBD Shares Go? Fal.Con Europe Could Be CrowdStrike’s Early Earnings Catalyst Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% Upside Boeing Takes Off as FAA Greenlights 737 MAX Production Boost Capital One Just Flashed a Buy Signal—New Highs Could Be Next Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
